PROGRESSIVE GASTROESOPHAGEAL REFLUX DISEASE IN ELDERLY PEOPLE AND RISK FACTORS
- Authors: Onuchina E.1, Tsukanov V.2, Kozlova N.3
-
Affiliations:
- Irkutsk State Medical Academy for Postgraduate and Continuing Education
- Research Institute of Medical Problems of the North, Siberian Branch, Russian Academy of Medical Sciences
- Ikutsk Diagnostic Center
- Issue: Vol 25, No 1 (2014)
- Pages: 69-71
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/115959
- ID: 115959
Cite item
Abstract
During a 5-year follow-up of elderly patients, the likelihood of transformation of nonerosive reflux disease (NERD) to erosive reflux disease (ERD) or Barretts esophagus (BE) was 46,4 and 2,5%, respectively. ERD was a stable form in 66,8% of the patients, it transformed to NERD or BE in 26,0 and 6,4%, respectively. Lower third esophageal dysplasia occurred in 8,1% of the patients with BE during the follow-up. In the elderly patients, the leading risk factors of progressive gastroesophageal reflux disease were the absence of maintenance therapy with proton pump inhibitors (odds ratio (OR) = 6,2%; confidence interval (CI), 1,8-8,8), abdominal obesity (OR 3,1; CI, 2,3-3,9), tobacco smoking (OR 2,3; CI, 1,5-3,1); regular alcohol use (OR, 2,0; CI, 1,1-2,7).
Full Text
About the authors
E. Onuchina
Irkutsk State Medical Academy for Postgraduate and Continuing Education
Email: elonu@mail.ru
MD
V. Tsukanov
Research Institute of Medical Problems of the North, Siberian Branch, Russian Academy of Medical Sciences
Email: elonu@mail.ru
Professor, MD
N. Kozlova
Ikutsk Diagnostic Center
Email: elonu@mail.ru
References
- Лазебник Л.Б. и др. Многоцентровое исследование «Эпидемиология гастроэзофагеальной рефлюксной болезни в России» (МЭГРЕ): первые итоги // Экспер. и клин. гастроэнтерол. - 2009; 6: 4-13.
- Онучина Е.В. и др. Применение препарата УДХК (Урсосан) в терапевтическом ведении больных ПБ // Экспер. и клин. гастроэнтерол. - 2010; 12: 96-101.
- El-Serag, H. et al. Update on the epidemiology of gastrooesophageal reflux disease: a systematic review // Gut. - 2013 Jul 13. Epub. ahead of print.
- Lien, H., Chang C., Yeh H. et al. Increasing prevalence of erosive esophagitis among Taiwanese aged 40 years and above: a comparison between two time periods // J. Clin. Gastroenterol. - 2009; 43 (10): 926-32.
- Lundell L., Dent J., Bennet J. Endoscopic assessment of oesophagitis clinical and fuctional correlates and futher validation of Los Angeles classification // Gut. - 1999; 45: 72-180.
- Malfertheiner P., Nocon M., Vieth M. et al. Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care-the ProGERD study // Aliment. Pharmacol. Ther. - 2012; 35 (1): 154-64.
- Miyamoto M., Haruma K., Kuwabara M. et al. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine // J. Gastroenterol. Hepatol. - 2007; 22 (5): 639-44.
- Pilotto A., Leandro G., Franceschi M. Ageing and Acid-Related Disease Study Group.Short- and long-term therapy for reflux oesophagitis in the elderly: a multicentre, placebo-controlled study with pantoprazole // Aliment. Pharmacol. Ther. -2003; 17 (11): 1399-406.
- Spechler S., Sharma P., Souza R. et al. American Gastroenterological Association technical review on the management of Barrett's esophagus // Gastroenterology. - 2011; 140 (3): 18-52.
- Vakil N., van Zanten S., Kahrilas P. et al. The Monreal Definition and Classification of gastroesophageal reflux disease: a global evidence-based consensus // Am. J. Gastroenterology. - 2006; 101: 1900-20.